IZRL vs. ARKG
IZRL (ARK Israel Innovative Technology ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - IZRL is a Technology Equities fund tracking the ARK Israeli Innovation Index, while ARKG is a Health & Biotech Equities fund actively managed by ARK. IZRL is passively managed, while ARKG is actively managed. Over the past 5 years, IZRL returned 0.63%/yr vs -15.72%/yr for ARKG. A 0.68 correlation means they provide meaningful diversification when combined. IZRL charges 0.49%/yr vs 0.75%/yr for ARKG.
Performance
IZRL vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IZRL achieves a 4.08% return, which is significantly lower than ARKG's 17.09% return.
IZRL
- 1D
- -2.54%
- 1M
- 1.92%
- YTD
- 4.08%
- 6M
- 7.41%
- 1Y
- 29.75%
- 3Y*
- 20.69%
- 5Y*
- 0.63%
- 10Y*
- —
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
IZRL vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IZRL ARK Israel Innovative Technology ETF | 4.08% | 36.94% | 15.28% | 11.39% | -38.61% | -3.55% | 34.12% | 21.75% | -6.17% | 1.69% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 0.51% |
Correlation
The correlation between IZRL and ARKG is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Dec 6, 2017 | 0.68 |
The correlation between IZRL and ARKG shifts across timeframes, from 0.52 (1 year) to 0.69 (5 years), reflecting how their relationship changes across market environments.
IZRL vs. ARKG - Sectors Allocation Comparison
Sectors
IZRL
ARKG
Technology
-
Healthcare
Communication Services
-
Industrials
-
Consumer Cyclical
-
Consumer Defensive
-
Financial Services
Basic Materials
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Technology
IZRL
ARKG
-
Healthcare
IZRL
ARKG
Communication Services
IZRL
ARKG
-
Industrials
IZRL
ARKG
-
Consumer Cyclical
IZRL
ARKG
-
Consumer Defensive
IZRL
ARKG
-
Financial Services
IZRL
ARKG
Basic Materials
IZRL
-
ARKG
-
Energy
IZRL
-
ARKG
-
Real Estate
IZRL
-
ARKG
-
Utilities
IZRL
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IZRL vs. ARKG — Risk / Return Rank
IZRL
ARKG
IZRL vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Israel Innovative Technology ETF (IZRL) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IZRL | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.08 | ||
| Sortino ratioReturn per unit of downside risk | +0.06 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.22 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | 1.95 | -0.31 |
| Martin ratioReturn relative to average drawdown | 4.81 | 4.67 | +0.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IZRL | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.39 | 1.31 | +0.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | -0.35 | +0.37 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.18 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.13 | +0.12 |
Drawdowns
IZRL vs. ARKG - Drawdown Comparison
The maximum IZRL drawdown since its inception was -59.98%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for IZRL and ARKG.
Loading charts...
Drawdown Indicators
| IZRL | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.98% | -83.59% | +23.61% |
Max Drawdown (1Y)Largest decline over 1 year | -18.27% | -27.51% | +9.24% |
Max Drawdown (3Y)Largest decline over 3 years | -24.60% | -51.96% | +27.36% |
Max Drawdown (5Y)Largest decline over 5 years | -53.21% | -80.18% | +26.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -15.42% | -69.65% | +54.23% |
Average DrawdownAverage peak-to-trough decline | -25.77% | -35.87% | +10.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.20% | 11.46% | -5.26% |
Volatility
IZRL vs. ARKG - Volatility Comparison
The current volatility for ARK Israel Innovative Technology ETF (IZRL) is 6.12%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.90%. This indicates that IZRL experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IZRL | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.12% | 11.90% | -5.78% |
Volatility (6M)Calculated over the trailing 6-month period | 16.26% | 28.77% | -12.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.57% | 41.12% | -19.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.27% | 45.61% | -21.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.84% | 41.12% | -16.28% |
IZRL vs. ARKG - Expense Ratio Comparison
IZRL has a 0.49% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
IZRL vs. ARKG - Dividend Comparison
IZRL's dividend yield for the trailing twelve months is around 2.49%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
IZRL ARK Israel Innovative Technology ETF | 2.49% | 2.59% | 0.45% | 0.00% | 0.00% | 0.34% | 0.00% | 2.15% | 3.08% | 0.00% |
Frequently Asked Questions
IZRL and ARKG have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to IZRL (6.12%). In terms of maximum drawdown, IZRL dropped -59.98% vs ARKG's -83.59%.
On 5-year performance, IZRL leads with 0.63% vs -15.72% for ARKG. On fees, IZRL is cheaper at 0.49% per year. On volatility, IZRL has been the lower-risk option at 6.12%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IZRL has performed better with a 0.63% return vs -15.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IZRL is cheaper with a 0.49% expense ratio, compared with 0.75% for ARKG.
IZRL has the higher dividend yield at 2.49%, compared with 0.00% for ARKG.
IZRL is categorized as Technology Equities, while ARKG is Health & Biotech Equities. Their fees differ too: 0.49% for IZRL and 0.75% for ARKG.
IZRL currently has the higher Sharpe Ratio (1.39 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IZRL and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer